Ertapenem - API

Ertapenem – API Manufactured by Unimark Remedies Limited, Bavla facility. Ertapenem is a broad-spectrum carbapenem antibiotic API, effective against a wide range of Gram-positive and Gram-negative bacteria. At Bavla, Unimark Remedies manufactures Ertapenem along with other key carbapenems, ensuring world-class quality through advanced fermentation and cGMP-compliant processes. The site delivers consistent global-standard APIs for partners across regulated and emerging markets. Imipenem + Cilastatin – API Manufactured at Unimark Remedies, Bavla. A combination of the carbapenem Imipenem with the dehydropeptidase inhibitor Cilastatin, this API is used in the treatment of severe bacterial infections. Produced under stringent cGMP standards, it ensures potency, stability, and reliable supply for global markets. Meropenem – API Manufactured at Unimark Remedies, Bavla. Meropenem is a broad-spectrum carbapenem antibiotic API widely used for serious hospital-acquired and multidrug-resistant infections. The Bavla site leverages advanced processes and strict quality compliance to deliver Meropenem APIs that meet international pharmacopeial requirements. Doripenem – API Manufactured at Unimark Remedies, Bavla. Doripenem is a potent carbapenem antibiotic API indicated for severe nosocomial and complicated intra-abdominal infections. With robust quality systems and cGMP-compliant manufacturing, Unimark’s Bavla facility ensures consistent, high-quality Doripenem supply. Faropenem – API Manufactured at Unimark Remedies, Bavla. Faropenem is an orally active penem antibiotic API with broad antibacterial coverage, serving as a valuable option for respiratory and urinary tract infections. The Bavla facility manufactures Faropenem with strict adherence to international regulatory standards, ensuring global market readiness.